Spangle Jennifer M, Roberts Thomas M
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
J Mol Med (Berl). 2017 Aug;95(8):791-798. doi: 10.1007/s00109-017-1546-0. Epub 2017 Jun 6.
Receptor tyrosine kinase (RTK) signaling cascades coordinate intracellular signaling in response to growth factors, chemokines, and other extracellular stimuli to control fundamental biological processes such as cellular proliferation, metabolism, and survival. Hyperactivation of pathways associated with growth factor signaling (e.g., RTK and downstream effectors including Ras, PI3K/AKT, and Raf) is a frequent event in human cancers, which uncouples ligand-mediated activation with signal transduction. While the contributions of direct genomic events are well understood as causative agents of hyperactive signal transduction, other non-heritable genomic modifications promote the activation of growth factor-associated signaling cascades. In this review, we highlight epigenomic mechanisms by which hyperactivation of RTK-associated signaling cascades occurs and may contribute to cancer.
受体酪氨酸激酶(RTK)信号级联反应可协调细胞内信号传导,以响应生长因子、趋化因子和其他细胞外刺激,从而控制细胞增殖、代谢和存活等基本生物学过程。与生长因子信号传导相关的通路(如RTK以及包括Ras、PI3K/AKT和Raf在内的下游效应器)的过度激活在人类癌症中是常见事件,它使配体介导的激活与信号转导解偶联。虽然直接基因组事件作为过度活跃信号转导的致病因素已得到充分理解,但其他非遗传性基因组修饰也会促进生长因子相关信号级联反应的激活。在本综述中,我们重点介绍RTK相关信号级联反应过度激活发生的表观基因组机制及其可能对癌症产生的影响。